Feb. 3, 2012 – There are just 10 days left to comment on an FDA draft report that explores the ... read more
Feb. 2, 2012 – More than four hours of testimony before the House Energy and Commerce Committee’s Subcommittee on Health ... read more
Jan. 27, 2012 – The Digital Advertising Alliance (DAA) last week launched its “Your AdChoices” public education campaign to inform ... read more
Jan. 26, 2012 – Avoiding conflict of interest in continuing medical education (CME) may seem like a daunting task, but ... read more
Jan. 20, 2012 – Common sense should tell people that some of celebrity chef Paula Deen’s infamously unhealthy dishes – ... read more
By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Jan. 17, 2012 – The Affordable Care Act ... read more
Jan. 6, 2012 — This article, written by Coalition for Healthcare Communication Executive Director John Kamp, was featured in the ... read more
Jan. 6, 2011 – As the pharmaceutical industry begins 2012, the FDA’s Office of Prescription Drug Promotion (OPDP) recommends that ... read more
Jan. 2, 2012 – In the waning days of 2011, the FDA released a significant draft guidance on company responses to ... read more
Dec. 15, 2011 – The Centers for Medicare & Medicaid Services (CMS) issued its long-awaited Proposed Rule for implementing the Physician ... read more
Dec. 12, 2011 — Facing a need to decrease spending and boost revenues, the federal government will continue to target ... read more
By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Nov. 14, 2011 — In response to ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication – Nov. 7, 2011 – Until the research labs and ... read more
Oct. 24, 2011 – After the U.S. Supreme Court struck down speaker- and content-based restrictions in Sorrell v. IMS Health, ... read more
Oct. 18, 2011 – A case filed by Par Pharmaceutical, Inc. against the FDA seeks to preserve Par’s First Amendment ... read more
Dec. 14, 2011 — UPDATE — CMS has published the proposed rules enforcing the Sunshine provisions of the Affordable Care ... read more
By John Kamp, Coalition for Healthcare Communication Executive Director Sept. 13, 2011 — Debates over health care and related ... read more
Aug. 1, 2011 — The recent Supreme Court decision in Sorrell v. IMS Health Inc. is earning robust commentary in ... read more
By Kenneth P. Berkowitz, Esq. July 21, 2011 — Why does the government fail to apply current regulatory requirements and ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication July 18, 2011 — For those who have not read the ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication June 29, 2011 — Yesterday I had the pleasure of moderating ... read more
March 31, 2011 — At a time when interaction between biopharmaceutical companies and physicians is under increased scrutiny, a recent ... read more
Read about it then comment here on our site.
The FDA launched a new program Tuesday to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful and not misleading. And the agency gave the outreach effort an apt name: The Bad Ad Program.
From Policy and Medicine:
Taking advantage of the new transparency and disclosure guidelines of several companies (Eli Lilly, Pfizer, GlaxoSmithKline, Cephalon and Merck), 2 recent articles discussed payments to doctors for their work with industry. Starting September 30, 2013, all payments made to physicians and teaching hospitals from U.S. manufacturers of drugs, biologics, medical devices and supplies will be posted on a public, searchable, online database for the Department of Health and Human Services (HHS).
Recent Comments